Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene Shares Continue to Rise

Shares in Stratagene rose 15.9 percent for the trading week ended Tuesday, a week after its shares had gained 17.4 percent. The firm had seen its shares slump to a 52-week low of $3.98 in the month leading up to the turnaround, but investors are clearly showing that they believe the stock was undervalued. The firm’s shares, however, have a long way to go before matching the 52-week high of $11.41.
 
Bruker led decliners for the tracking period, closing down 5.7 percent for the week. The firm’s shares have recently been trading near their 52-week high of $7.33, which was reached at the end of August.
 
Overall, the BCW Index gained 1 percent for the week. In comparison, the Dow Jones Industrial Average was up .4 percent, the Nasdaq gained .3 percent, and the Nasdaq Biotech Index slipped .3 percent.
 
 

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(September 19, 2006)
Last Price
(September 12, 2006)
% change
Agilent
A
31.45
31.50
-0.2
Applied Biosystems
ABI
33.11
33.15
-0.1
Beckman
BEC
56.77
55.26
2.7
Bio-Rad
BIO
70.24
71.59
-1.9
Bruker
BRKR
6.80
7.21
-5.7
Fisher Scientific
FSH
79.46
78.20
1.6
GE
GE
34.85
34.67
0.5
Invitrogen
IVGN
64.42
63.34
1.7
Millipore
MIL
65.21
62.70
4.0
Molecular Devices
MDCC
23.08
23.51
-1.8
PerkinElmer
PKI
18.45
18.69
-1.3
Qiagen
QGEN
14.76
14.21
3.9
Sigma
SIAL
73.43
73.20
0.3
Stratagene
STGN
6.40
5.52
15.9
Thermo
TMO
40.00
39.30
1.8
Waters
WAT
44.02
44.10
-0.2
BCW Index Average
41.40
41.01
1.0
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.